0001206774-11-001350.txt : 20110608 0001206774-11-001350.hdr.sgml : 20110607 20110608100748 ACCESSION NUMBER: 0001206774-11-001350 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20110608 DATE AS OF CHANGE: 20110608 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: URRY JAMES A CENTRAL INDEX KEY: 0001083167 FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: 1001 MURPHY RANCH ROAD CITY: MILPITAS STATE: CA ZIP: 95035 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: LYRIS, INC. CENTRAL INDEX KEY: 0001166220 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 010579490 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-78509 FILM NUMBER: 11900095 BUSINESS ADDRESS: STREET 1: 6401 HOLLIS STREET STREET 2: SUITE 125 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 800-768-2929 MAIL ADDRESS: STREET 1: 6401 HOLLIS STREET STREET 2: SUITE 125 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: JL HALSEY CORP DATE OF NAME CHANGE: 20020129 SC 13D/A 1 lyris_sc13da.htm AMENDMENT TO SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP lyris_sc13da.htm
OMB APPROVAL
OMB Number:
3235-0145
   		  
Expires:   February 28, 2009
Estimated average
burden hours per
response. .  14.5
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
 
SCHEDULE 13D
 
Under the Securities Exchange Act of 1934
 
(Amendment No. 2)*
 
Lyris, Inc. (LYRI.OB)
(Name of Issuer)
 
Common Stock, par value $0.01 per share
(Title of Class of Securities)
 
46622H 10 3
(CUSIP Number)

James A. Urry
PO Box 242
Locust Valley, NY 11560
212-752-6261
 
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

May 20, 2011
(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o
 
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.
 
* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
 
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 

CUSIP No. 4662HH 10 3
 
1.          Names of Reporting Persons.
    I.R.S. Identification Nos. of above persons (entities only)
    Meudon Investments/56-2306103
     
2.   Check the Appropriate Box if a Member of a Group (See Instructions)
     
    (a)   o
    (b)   o
         
3.   SEC Use Only
     
     
4.   Source of Funds (See Instructions)
    WC    
         
5.   Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)   o
     
6.   Citizenship or Place of Organization
    New York
     
    7.            Sole Voting Power
        10,060,606
         
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With		 8.   Shared Voting Power
    0
     
9.   Sole Dispositive Power
    10,060,606
         
    10.   Shared Dispositive Power
        0
         
11.   Aggregate Amount Beneficially Owned by Each Reporting Person
    10,060,606
     
12.   Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o
     
     
13.   Percent of Class Represented by Amount in Row (11)
    8.3 %  
     
14.   Type of Reporting Person (See Instructions)
    PN    

2
 
 

CUSIP No. 4662HH 10 3
 
1.        Names of Reporting Persons.
    I.R.S. Identification Nos. of above persons (entities only)
    James A. Urry
     
2.   Check the Appropriate Box if a Member of a Group (See Instructions)
     
    (a)   o
    (b)   o
         
3.   SEC Use Only
     
     
4.   Source of Funds (See Instructions)
    WC    
         
5.   Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)   o
     
6.   Citizenship or Place of Organization
    United States of America
     
    7.            Sole Voting Power
        10,060,606
         
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With		 8.   Shared Voting Power
    0
     
9.   Sole Dispositive Power
    10,060,606
         
    10.   Shared Dispositive Power
        0
         
11.   Aggregate Amount Beneficially Owned by Each Reporting Person
    10,060,606
     
12.   Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o
     
     
13.   Percent of Class Represented by Amount in Row (11)
    8.3 %  
     
14.   Type of Reporting Person (See Instructions)
    IN    

3 
 
 

This Amendment No. 2 to Schedule 13D amends and supplements Item 3-6 in the Schedule 13D initially filed on April 22, 2010 by James A. Urry and subsequently amended on August 27, 2011 with respect to the common stock, par value $0.01 per share of Lyris, Inc. par value $0.01 per share (the “Common Stock”) of Lyris, Inc. (the “Issuer”).
 
Item 3. Source and Amount of Funds or Other Consideration
 
On May 20, 2011, Meudon Investments directly acquired 2,500,000 shares of the Issuer’s Common Stock in a private transaction at a purchase price of $0.24 per share (the “Purchase”). The aggregate purchase price of $600,000 was paid from the working capital funds of Meudon Investments. Mr. Urry has sole voting an dispositive power of such shares held by Meudon Investments.
 
Item 4. Purpose of Transaction
 
The Purchase is for investment purposes only. Neither Mr. Urry nor Meudon Investments has any plans or proposals which relate to or would result in any of the actions described in items (a) through (j) of Item 4 of Schedule 13D with respect to the shares purchased in this transaction
 
Item 5. Interest in Securities of the Issuer
 
(a)-(b) Meudon Investments owns a total of 10,060,606 shares of the Common Stock of the Issuer. Mr. Urry has sole voting and dispositive power over all of the common stock owned by Meudon Investments and may therefore be deemed to beneficially own in the aggregate 10,060,606 shares of Common Stock of the Issuer, representing approximately 8.3% of the outstanding shares of Common Stock of the Issuer.
 
(c) Reference is made to Item 3.
 
(d)-(e) Not applicable.
 
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer
 
None
 
Item 7. Material to Be Filed as Exhibits
 
Exhibit A: Joint Filing Statement as required by Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, filed as Exhibit 99.1 to the Schedule 13D filed by James A. Urry and Meudon Investments on April 22, 2010, and incorporated herein by reference.
 
4
 
 

SIGNATURE
 
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
 
 
Dated: June 7, 2011       /s/ James A. Urry
        James A. Urry
     
    Meudon Investments
     
Dated: June 7, 2011       By: /s/ James A. Urry
        James A. Urry
        General Partner

5